Total Visits

Views
Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? 95

Total Visits Per Month

April 2020May 2020June 2020July 2020August 2020September 2020October 2020
Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? 2 2 4 2 2 1 7

Top country views

Views
United States 47
China 31
Qatar 7
Germany 3
United Kingdom 1
Netherlands 1

Top cities views

Views
Ashburn 16
Zhengzhou 14
Shanghai 8
Ann Arbor 7
Fairfield 6
Jinan 5
Shenzhen 4
Cambridge 2
Encino 2
Houston 2